DK168381B1 - Salte mellem ranitidin og vismuthcarboxylsyrekomplekser, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende saltene - Google Patents

Salte mellem ranitidin og vismuthcarboxylsyrekomplekser, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende saltene Download PDF

Info

Publication number
DK168381B1
DK168381B1 DK351789A DK351789A DK168381B1 DK 168381 B1 DK168381 B1 DK 168381B1 DK 351789 A DK351789 A DK 351789A DK 351789 A DK351789 A DK 351789A DK 168381 B1 DK168381 B1 DK 168381B1
Authority
DK
Denmark
Prior art keywords
methyl
bismuth
salt
ranitidine
complex
Prior art date
Application number
DK351789A
Other languages
Danish (da)
English (en)
Other versions
DK351789D0 (da
DK351789A (da
Inventor
John Watson Clitherow
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888817098A external-priority patent/GB8817098D0/en
Priority claimed from GB898904686A external-priority patent/GB8904686D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK351789D0 publication Critical patent/DK351789D0/da
Publication of DK351789A publication Critical patent/DK351789A/da
Application granted granted Critical
Publication of DK168381B1 publication Critical patent/DK168381B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DK351789A 1988-07-18 1989-07-17 Salte mellem ranitidin og vismuthcarboxylsyrekomplekser, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende saltene DK168381B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8817098 1988-07-18
GB888817098A GB8817098D0 (en) 1988-07-18 1988-07-18 Chemical compounds
GB8904686 1989-03-01
GB898904686A GB8904686D0 (en) 1989-03-01 1989-03-01 Chemical compounds

Publications (3)

Publication Number Publication Date
DK351789D0 DK351789D0 (da) 1989-07-17
DK351789A DK351789A (da) 1990-01-19
DK168381B1 true DK168381B1 (da) 1994-03-21

Family

ID=26294175

Family Applications (1)

Application Number Title Priority Date Filing Date
DK351789A DK168381B1 (da) 1988-07-18 1989-07-17 Salte mellem ranitidin og vismuthcarboxylsyrekomplekser, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende saltene

Country Status (35)

Country Link
US (1) US5008256A (pl)
JP (1) JP2523185B2 (pl)
KR (1) KR0122598B1 (pl)
CN (1) CN1022626C (pl)
AT (1) AT398200B (pl)
AU (1) AU632052B2 (pl)
BE (1) BE1003254A5 (pl)
CA (1) CA1332610C (pl)
CH (1) CH679582A5 (pl)
CY (1) CY1650A (pl)
DE (1) DE3923638C2 (pl)
DK (1) DK168381B1 (pl)
EG (1) EG19368A (pl)
ES (1) ES2014175A6 (pl)
FI (1) FI90538C (pl)
FR (1) FR2634122B1 (pl)
GB (1) GB2220937B (pl)
GR (1) GR1000431B (pl)
HK (1) HK61392A (pl)
HU (2) HU206104B (pl)
IE (1) IE61076B1 (pl)
IL (1) IL91005A (pl)
IT (1) IT1231481B (pl)
LU (2) LU88722I2 (pl)
MX (1) MX174145B (pl)
MY (1) MY104055A (pl)
NL (2) NL192604C (pl)
NO (2) NO176319C (pl)
NZ (1) NZ229958A (pl)
PL (1) PL162391B1 (pl)
PT (1) PT91188B (pl)
SE (1) SE468715B (pl)
SG (1) SG51992G (pl)
YU (1) YU47021B (pl)
ZW (1) ZW8689A1 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
US5843482A (en) * 1990-07-20 1998-12-01 Tillotts Pharma Ag Products and processes for the treatment of the alimentary canal
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
WO1996019232A1 (en) * 1994-12-19 1996-06-27 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
EP1035192A1 (de) * 1999-01-26 2000-09-13 Stefan Graichen Additiv für einen Kühlschmierstoff
CN1102585C (zh) * 1999-04-28 2003-03-05 常州兰陵制药有限公司 雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CN100402514C (zh) * 2006-08-01 2008-07-16 丽珠医药集团股份有限公司 一种制备枸橼酸铋雷尼替丁的方法
AU2007216671B2 (en) * 2007-07-09 2009-07-16 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
CN102408398B (zh) * 2011-09-20 2012-12-05 江苏汉斯通药业有限公司 枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) * 2014-03-28 2015-11-18 常州兰陵制药有限公司 枸橼酸铋雷尼替丁的制备方法
WO2015155297A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
CN107382921A (zh) * 2017-07-28 2017-11-24 常州兰陵制药有限公司 制备枸橼酸铋雷尼替丁的方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) * 1986-08-05 1986-12-01 Hasunor Ag Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
KR910002826A (ko) 1991-02-26
JPH02117684A (ja) 1990-05-02
FI90538C (fi) 1994-02-25
CN1022626C (zh) 1993-11-03
CH679582A5 (pl) 1992-03-13
MX174145B (es) 1994-04-25
LU87557A1 (fr) 1990-07-24
GB2220937B (en) 1991-11-27
NL192604B (nl) 1997-07-01
HUT52082A (en) 1990-06-28
FI90538B (fi) 1993-11-15
IT8948196A0 (it) 1989-07-17
NZ229958A (en) 1991-09-25
NO176319B (no) 1994-12-05
EG19368A (en) 1995-02-28
NO1998007I1 (no) 1998-02-05
CN1039419A (zh) 1990-02-07
IL91005A (en) 1994-10-07
AT398200B (de) 1994-10-25
NO176319C (no) 1995-03-15
SG51992G (en) 1992-07-24
DE3923638C2 (de) 1995-11-23
SE8902550L (sv) 1990-01-19
PL162391B1 (pl) 1993-10-30
NL192604C (nl) 1997-11-04
KR0122598B1 (ko) 1997-11-13
JP2523185B2 (ja) 1996-08-07
ES2014175A6 (es) 1990-06-16
NL970046I1 (nl) 1998-03-02
FI893448A0 (fi) 1989-07-17
AU3817889A (en) 1990-01-18
FR2634122B1 (fr) 1993-11-19
FR2634122A1 (fr) 1990-01-19
US5008256A (en) 1991-04-16
LU88722I2 (fr) 1996-08-23
NO892936D0 (no) 1989-07-17
GR890100454A (en) 1990-06-27
HK61392A (en) 1992-08-21
PT91188A (pt) 1990-02-08
ZW8689A1 (en) 1990-02-21
MY104055A (en) 1993-10-30
AU632052B2 (en) 1992-12-17
HU211173A9 (en) 1995-11-28
CA1332610C (en) 1994-10-18
BE1003254A5 (fr) 1992-02-11
NL970046I2 (nl) 1998-04-01
NL8901840A (nl) 1990-02-16
IE892309L (en) 1990-01-18
HU206104B (en) 1992-08-28
NO892936L (no) 1990-01-19
DK351789D0 (da) 1989-07-17
SE8902550D0 (sv) 1989-07-17
SE468715B (sv) 1993-03-08
CY1650A (en) 1992-12-11
PT91188B (pt) 1995-03-01
DE3923638A1 (de) 1990-03-01
DK351789A (da) 1990-01-19
IE61076B1 (en) 1994-09-21
YU47021B (sh) 1994-11-15
GB8916288D0 (en) 1989-08-31
YU142789A (en) 1991-04-30
FI893448A (fi) 1990-01-19
GR1000431B (el) 1992-07-30
IT1231481B (it) 1991-12-07
MX16829A (es) 1993-10-01
IL91005A0 (en) 1990-02-09
GB2220937A (en) 1990-01-24
ATA172889A (de) 1994-02-15

Similar Documents

Publication Publication Date Title
DK168381B1 (da) Salte mellem ranitidin og vismuthcarboxylsyrekomplekser, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende saltene
KR20050040837A (ko) 아세트산아닐리드 유도체의 α형 또는 β형 결정
JP2915021B2 (ja) カルボン酸誘導体
AU639980B2 (en) Salts of ranitidine formed with zinc(II) complexes of carboxylic acids
US5229418A (en) Carboxylic acid derivatives
US4515806A (en) Furan derivatives and addition salts thereof pharmaceutical compositions and the therapeutical applications thereof
RU2114857C1 (ru) Соли, образованные ранитидином и комплексным соединением висмута с карбоновой кислотой, и фармацевтический препарат
CZ285821B6 (cs) Sůl tvořená ranitidinem a komlexem vizmutu s karboxylovou kyselinou, farmaceutický prostředek s obsahem této soli a způsob přípravy uvedené soli
US4215143A (en) Anti-ulcer pharmaceutical composition containing inositol hexasulfate aluminum or sodium aluminum salt as active ingredient
US4207339A (en) Anti-ulcer pharmaceutical composition containing inositol hexasulfate or an alkaline metal salt thereof as active ingredient
DE2828951A1 (de) 3- eckige klammer auf (4-chromanyliden)amino eckige klammer zu -2-oxazolidinone
SI8911427A (sl) Postopek za pripravo soli ranitidina z bizmutovimi kompleksi karboksilnih kislin
JPS60163930A (ja) ポリシルセスキオキサン

Legal Events

Date Code Title Description
PBP Patent lapsed

Ref document number: DK

CTFL Supplementary protection certificate (spc) lapsed

Free format text: PRODUCT NAME: RANITIDINBISMUTHCITRAT

Spc suppl protection certif: CA 1995 00021

Filing date: 19951130